Skip to main content
. 2019 Feb;10(1):85–94. doi: 10.21037/jgo.2018.10.06

Table 3. Median survival, 12 months survival and 60 months survival by histology.

Histology No. of subject Event Censored Median survival, months (95% CI) 12-month survival 60-month survival
Adenocarcinoma 60,052 44,965 (75%) 15,087 (25%) 13.2 (13.0–13.4) 52.4% (52.0–52.8%) 21.6% (21.2–21.9%)
Adenosquamous carcinoma 327 265 (81%) 62 (19%) 9.9 (8.6–11.2) 42.4% (36.9–47.7%) 14.7% (10.5–19.6%)
Squamous cell carcinoma 836 660 (79%) 176 (21%) 8.9 (7.7–10.6) 43.7% (40.3–47.1%) 17.4% (14.6–20.4%)